| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |